Research graph
References from Ultrasound Targeted Apoptosis Imaging in Monitoring Early Tumor Response of Trastuzumab in a Murine Tumor Xenograft Model of Her-2–Positive Breast Cancer1. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2012 · External reference
Targeting the function of the HER2 oncogene in human cancer therapeutics
10.1038/sj.onc.1210478 · 2007 · External reference
Progress and new standards of care in the management of HER-2 positive breast cancer
10.1016/j.ejca.2006.10.020 · 2007 · External reference
Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials
10.1016/j.ctrv.2012.03.009 · 2013 · External reference
Experience in large-core needle biopsy in the diagnosis of 1431 breast lesions
10.1007/s12032-010-9494-3 · 2011 · External reference
Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer
10.1158/1078-0432.ccr-08-2635 · 2009 · External reference
Trastuzumab
10.1634/theoncologist.2010-0035 · 2011 · External reference
Mechanisms of resistance to HER2 target therapy
10.1093/jncimonographs/lgr026 · 2011 · External reference
Increased uptake of the apoptosis-imaging agent 99mTc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis
2002 · External reference
Innovative strategies in in vivo apoptosis imaging
10.2174/092986708783330647 · 2008 · External reference
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
10.1182/blood.v84.5.1415.bloodjournal8451415 · 1994 · External reference
HER2 breast cancer therapies: a review
2009 · External reference
Molecular imaging and targeted therapies
10.1016/j.bcp.2010.04.011 · 2010 · External reference
A differential PCR assay for the detection of c-erbB 2 amplification used in a prospective study of breast cancer
10.1136/mp.50.5.254 · 1997 · External reference
Advances in molecular imaging for breast cancer detection and characterization
10.1186/bcr3094 · 2012 · External reference
Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy
10.7863/jum.2012.31.10.1543 · 2012 · External reference
Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent
10.1097/rli.0b013e3182034fed · 2011 · External reference
A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature
10.7863/jum.2011.30.7.921 · 2011 · External reference
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size
2000 · External reference
Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer
10.1158/1078-0432.ccr-08-0239 · 2008 · External reference
Quantitative tumor apoptosis imaging using technetium-99m–HYNIC annexin V single photon emission computed tomography
10.1200/jco.2003.12.096 · 2003 · External reference
Magneto/optical annexin V, a multimodal protein
10.1021/bc049905i · 2004 · External reference
Molecular ultrasound assessment of tumor angiogenesis
10.1007/s10456-010-9175-z · 2010 · External reference
Flow cytometry of apoptotic cell death
10.1016/s0022-1759(00)00233-7 · 2000 · External reference
